Developmental Dysplasia of the Hip
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 20-40 years; 2. Patients whose developmental hip dysplasia is confirmed by imaging results combined with the duration of symptoms; 3. Patients undergoing their first periacetabular osteotomy; 4. Patients who can tolerate the intensity of rehabilitation training; 5. Patients with good cognitive function, able to cooperate with and complete various rehabilitation treatments; 6. Subjects who voluntarily participate in the study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who had lower limb joint surgery within 1 year before the operation; 2. Acute trauma or fracture of the lower limbs, systemic or neurological diseases; 3. Patients who have previously undergone PAO surgery on the contralateral side; 4. History of hip joint surgery on the same side; 5. Patients with other diseases or adverse health conditions that the investigator believes may affect their participation in this study, such as malignant diseases, serious illnesses, alcohol or drug addiction, or mental disorders; 6. Patients with obvious limited hip joint movement and other complications affecting the hip joint (such as hip impingement syndrome, femoral head necrosis, congenital clubfoot); 7. Patients currently participating in another clinical study; 8. Patients whom the investigator believes are not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hip function (iHOT-33 score); | — |
Secondary
| Measure | Time frame |
|---|---|
| Muscle strength (peak torque of major hip musculature);Joint range of motion (active and passive range of motion);Pain;Hip-related quality of life (HOS-ADL and HOS-SSS scores);Plantar pressure;Balance function;Anxiety level; | — |
Countries
China
Contacts
the Fourth Medical Center of PLA General Hospital